In a further study, METTL3 also promoted maturation of miRNA-221-3p in an m6A-dependent manner, which negatively regulated HIPK2, upregulated the target gene Che-1, and induced chemoresistance of breast cancer cells to doxorubicin (Pan et al., 2021). The gene discussed is METTL3; the disease is breast carcinoma.